Ivan is a Partner of L1 Health and responsible for developing and shaping investment strategy, leading deal execution and advising portfolio management. He serves as a Board Member of K2 HealthVentures and Destination Pet.
Prior to L1 Health, he served as Director of Corporate Development of the LetterOne Group and as a Board member of L1 Treasury. Before joining LetterOne, he worked as Deputy Director of Investment Planning of the Alfa Group Consortium. Ivan started his career at Johnson & Johnson Medical Devices & Diagnostics followed by several years in investment banking and private equity.
Ivan is a Harvard Business School alumni and completed the International Directors Program at INSEAD. Ivan holds an MA in Economics from the New Economic School in Moscow and a degree in Applied Mathematics and Computer Science from Moscow State University.